Fr1da Early Diagnosis and Care of Type 1 Diabetes
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The Fr1da study: Early diagnosis and care of type 1 diabetes aims to carry out a comprehensive, population-based screening for the early diagnosis of type 1 diabetes as part of the U7 to U11 preventive medical check-up for children or between the ages of 2 and 10 years in Bavaria and to implement it in other federal states. Screening is recommended at two time points: 1st screening at the age of 3 years (U7a) and 2nd screening at the age of 7 years (U10). In addition, relatives of patients with type 1 diabetes between the ages of 1 and 21 can be screened repeatedly at intervals of 3 to 5 years for an early-stage of type 1 diabetes.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Maximum Age: 10
Healthy Volunteers: t
View:
• written informed consent by one custodial parent
Locations
Other Locations
Germany
Institut für Diabetesforschung, Helmholtz Zentrum München
RECRUITING
Munich
Contact Information
Primary
Anette-Gabriele Ziegler, Prof.Dr.med.
diabetes.frueherkennung@helmholtz-muenchen.de
+49 800-4648835
Time Frame
Start Date: 2015-02
Estimated Completion Date: 2028-12
Participants
Target number of participants: 285000
Related Therapeutic Areas
Sponsors
Leads: Helmholtz Zentrum München